乳腺癌幸存者的生物衰老的转录体标志物:一项纵向研究
Judith E Carroll1,2,3, Catherine M Crespi3,4, Steve Cole1,2,3,5
1Cousins Center for Psychoneuroimmunology, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles (UCLA), Los Angeles, CA, USA.
Journal of the National Cancer Institute
|October 7, 2024
概括
乳腺癌治疗加速生物衰老,通过免疫细胞中细胞衰老和DNA损伤标记的增加来表明这一点. 与单独的辐射相比,有或没有辐射的化疗显示出持续的衰老效应.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 衰老研究研究 衰老研究
背景情况:
- 乳腺癌疗法可以影响长期的健康和衰老过程.
- 了解治疗诱导衰老的分子机制对于幸存者护理至关重要.
研究的目的:
- 研究乳腺癌治疗对生物衰老标志物的影响.
- 分析与细胞衰老,DNA损伤和治疗后炎症相关的基因表达.
主要方法:
- 在放射治疗 (RT) 和/或化疗 (CT) 之前和后2年内对患有乳腺癌 (阶段0-III) 的妇女进行长度研究.
- 对外围血液单核细胞的RNA测序,以评估基因表达.
- 使用混合线性模型和零膨胀两部分模型进行统计分析.
主要成果:
- 与RT或单独手术相比,使用或不使用放射治疗 (RT) 的化疗 (CT) 与治疗后检测到p16INK4a表达的几率更高.
- 所有治疗组都显示了p16INK4a,DNA损伤反应,SenMayo和老化相关的分泌表型随着时间的推移而增加.
- 与单独RT相比,使用或不使用RT的化疗显示出DNA损伤反应,SenMayo和衰老相关的分泌表型增加的明显模式.
结论:
- 乳腺癌治疗激活与生物衰老相关的基因,包括细胞衰老和炎症反应,从诊断到早期生存.
- 虽然在治疗过程中观察到衰老标志物的增加,但化疗导致持续增加,而放射治疗后来显示出减缓效果.
- 研究结果表明,接受乳腺癌治疗的妇女的免疫细胞表现出加速的生物衰老.
相关概念视频
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Telomeres and Telomerase
5.1K
5.1K
Cancer Survival Analysis
329
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
329


